Researchers are devising a blood test screening for 11 newly discovered biomarkers of dementia. They say the test could predict its development 15 years before symptom onset.
By using ultrasound, a team of researchers has managed to get aducanumab, an Alzheimer's drug, through the blood-brain barrier and straight to the brain of patients.